New eye drug tested for patients failing standard wet AMD treatment
Disease control
Completed
This was a first-in-human study to check the safety of a new eye injection called PMC-403 for wet age-related macular degeneration (AMD). It involved 17 participants whose vision was still declining despite receiving standard anti-VEGF injections. The main goal was to find the hi…
Phase: PHASE1 • Sponsor: PharmAbcine • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC